Mankind Pharma Limited (MANKIND.BO)
INR 2343.55
(-1.47%)
INR 2343.55
(-1.47%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 28.09 Billion INR | 30.42% |
| 2022 | 20.26 Billion INR | -6.99% |
| 2021 | 21.46 Billion INR | 17.12% |
| 2020 | 18.16 Billion INR | 10.64% |
| 2019 | 15.4 Billion INR | 72.39% |
| 2018 | 9.35 Billion INR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 6.81 Billion INR | 14.51% |
| 2023 Q1 | 7.18 Billion INR | 72.35% |
| 2023 Q3 | 6.81 Billion INR | -8.69% |
| 2023 FY | - INR | 30.42% |
| 2023 Q4 | 5.91 Billion INR | -13.23% |
| 2023 Q2 | 7.46 Billion INR | 3.89% |
| 2022 Q4 | 4.16 Billion INR | -12.3% |
| 2022 Q2 | 6.21 Billion INR | 30.59% |
| 2022 Q3 | 4.75 Billion INR | -23.6% |
| 2022 FY | - INR | -6.99% |
| 2022 Q1 | 4.76 Billion INR | 60.75% |
| 2021 Q4 | 2.96 Billion INR | 0.0% |
| 2021 FY | - INR | 17.12% |
| 2020 FY | - INR | 10.64% |
| 2019 FY | - INR | 72.39% |
| 2018 FY | - INR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 9.61 Billion INR | -192.145% |
| Aurobindo Pharma Limited | 61.78 Billion INR | 54.53% |
| Glenmark Life Sciences Limited | 6.86 Billion INR | -309.371% |
| Granules India Limited | 8.6 Billion INR | -226.537% |
| Indoco Remedies Limited | 2.64 Billion INR | -961.356% |
| Achyut Healthcare Limited | 524 Thousand INR | -5361477.863% |
| Ajanta Pharma Limited | 12.56 Billion INR | -123.588% |
| Alkem Laboratories Limited | 24.19 Billion INR | -16.117% |
| Alpa Laboratories Limited | 86.12 Million INR | -32520.047% |
| Brooks Laboratories Limited | 41.72 Million INR | -67228.096% |
| AstraZeneca Pharma India Limited | 2.35 Billion INR | -1092.068% |
| Bajaj HealthCare Limited | 444.51 Million INR | -6220.283% |
| Bliss GVS Pharma Limited | 1.47 Billion INR | -1799.533% |
| Dr. Reddy's Laboratories Limited | 88.27 Billion INR | 68.174% |
| Eris Lifesciences Limited | 6.98 Billion INR | -302.131% |
| FDC Limited | 4.4 Billion INR | -538.27% |
| Glenmark Pharmaceuticals Limited | 11.34 Billion INR | -147.668% |
| Gufic Biosciences Limited | 1.48 Billion INR | -1797.665% |
| Ind-Swift Laboratories Limited | 6.86 Billion INR | -309.446% |
| Ipca Laboratories Limited | 13.29 Billion INR | -111.246% |
| Jagsonpal Pharmaceuticals Limited | 323.46 Million INR | -8585.67% |
| Krebs Biochemicals & Industries Limited | -82.72 Million INR | 34060.7% |
| Lasa Supergenerics Limited | -65.08 Million INR | 43269.435% |
| Laurus Labs Limited | 8 Billion INR | -250.92% |
| Lupin Limited | 36.96 Billion INR | 24.006% |
| Medicamen Biotech Limited | 245.66 Million INR | -11336.403% |
| Medico Remedies Limited | 150.37 Million INR | -18582.698% |
| Megasoft Limited | 284.73 Million INR | -9767.091% |
| NATCO Pharma Limited | 18.79 Billion INR | -49.479% |
| Piramal Pharma Limited | 13.05 Billion INR | -115.196% |
| RPG Life Sciences Limited | 1.28 Billion INR | -2092.327% |
| Sigachi Industries Limited | 883.39 Million INR | -3080.296% |
| Sun Pharmaceutical Industries Limited | 138.36 Billion INR | 79.695% |
| Suven Pharmaceuticals Limited | 4.67 Billion INR | -500.675% |
| Syncom Formulations (India) Limited | 430.27 Million INR | -6429.453% |
| Unichem Laboratories Limited | 742.35 Million INR | -3684.528% |
| Wanbury Limited | 985.49 Million INR | -2750.832% |
| Windlas Biotech Limited | 781.72 Million INR | -3493.955% |
| ZIM Laboratories Limited | 462.09 Million INR | -5979.82% |
| Zydus Lifesciences Limited | 56.22 Billion INR | 50.029% |
| Sun Pharma Advanced Research Company Limited | -3.73 Billion INR | 852.952% |
| Divi's Laboratories Limited | 25.43 Billion INR | -10.478% |
| Hester Biosciences Limited | 539.47 Million INR | -5107.828% |
| Procter & Gamble Health Limited | 3.01 Billion INR | -832.015% |
| Amrutanjan Health Care Limited | 682.53 Million INR | -4016.206% |
| Bal Pharma Limited | 345.59 Million INR | -8029.432% |
| Strides Pharma Science Limited | 3.76 Billion INR | -646.27% |
| Venus Remedies Limited | 711.8 Million INR | -3846.983% |
| Aarti Pharmalabs Limited | 3.9 Billion INR | -618.64% |
| Nectar Lifesciences Limited | 1.56 Billion INR | -1696.575% |
| Shilpa Medicare Limited | 2.58 Billion INR | -985.582% |
| Aarti Drugs Limited | 3.24 Billion INR | -764.816% |
| IOL Chemicals and Pharmaceuticals Limited | 2.6 Billion INR | -977.828% |
| Suven Life Sciences Limited | -992.78 Million INR | 2929.899% |
| Ind-Swift Limited | 1.06 Billion INR | -2537.834% |
| Valiant Laboratories Limited | 12.73 Million INR | -220440.608% |
| J. B. Chemicals & Pharmaceuticals Limited | 9.33 Billion INR | -200.967% |
| Solara Active Pharma Sciences Limited | -2.82 Billion INR | 1095.594% |
| Themis Medicare Limited | 562.6 Million INR | -4893.658% |
| Hikal Limited | 2.69 Billion INR | -943.546% |
| Torrent Pharmaceuticals Limited | 35 Billion INR | 19.752% |
| Sequent Scientific Limited | 549.8 Million INR | -5009.98% |
| Novartis India Limited | 1.26 Billion INR | -2113.399% |
| Wockhardt Limited | 1.08 Billion INR | -2501.358% |
| Jubilant Pharmova Limited | 8 Billion INR | -250.92% |
| Biofil Chemicals and Pharmaceuticals Limited | 13.06 Million INR | -214987.031% |
| Neuland Laboratories Limited | 4.74 Billion INR | -491.693% |
| Morepen Laboratories Limited | 1.72 Billion INR | -1527.776% |
| Kilitch Drugs (India) Limited | 287.42 Million INR | -9674.608% |
| Mangalam Drugs & Organics Limited | 174.94 Million INR | -15959.051% |